Efficacy and Safety of BI 10773 in Combination With Insulin in Patients With Type 2 Diabetes

Update Il y a 7 mois
Reference: NCT01011868

Woman and Man


The objective of the current study is to investigate the efficacy, safety and tolerability of BI 10773 at two different doses compared to placebo during long term treatment (78 weeks) in combination with basal insulin in patients with type 2 diabetes mellitus with insufficient glycaemic control.

Inclusion criteria

  • Diabetes Mellitus, Type 2